The Cynosure buy at $5.35 (vs. current ~$6.50-6.98 range for other insiders) suggests a negotiated block or strategic accumulation. Combined with the registration rights amendment giving Cynosure additional demand registration rights, this may signal preparation for a secondary offering or liquidity event. Monitor for a Form 144 filing or S-1 registration — the cluster's size and timing (post-strong earnings, pre-potential offering) is unusually informative.
Price Chart
Executive Summary
A major insider buying cluster at BRCB, led by a $64.4M open-market purchase by director/10% owner Cynosure Group at $5.35/share, alongside smaller buys from the COO ($293K), Principal Accounting Officer ($50K), and CMO ($20K). The cluster follows a strong Q1 earnings beat (revenue +23.7%, net income swing to $1.8M from -$0.9M) and a registration rights amendment giving Cynosure additional demand registration rights, suggesting the large buy may be tied to a negotiated block or strategic positioning ahead of a potential secondary offering.
Key Financial Metrics
Key Facts
- Cynosure Group (director, 10% owner) purchased 12.04M shares at $5.35 for $64.43M on 2026-05-15
- COO Clay Geyer bought 45,080 shares at $6.51 for $293K on 2026-05-21
- Principal Accounting Officer Michael Schmidt bought 7,100 shares at $6.98 for $50K on 2026-05-20
- CMO Jessica Wegener-Beyer bought 3,098 shares at $6.46 for $20K on 2026-05-20
- Total cluster value: $64.79M, representing ~19.7% of BRCB's $329M market cap
- Q1 2026 revenue grew 23.7% YoY to $55.5M; net income improved to $1.8M from -$0.9M
- Registration rights amendment (May 15) gave Cynosure investors up to 4 demand registration requests (up from 3 for founder group)
- Full-year 2026 guidance reaffirmed: revenue $255-257M, adjusted EBITDA $33.5-34.5M
Financial Impact
Insider purchases totaling $64.79M, or ~19.7% of market cap, concentrated in a single 10% owner buy of $64.43M
Risk Factors
- The Cynosure buy at $5.35 may reflect a negotiated price below market, not necessarily a bullish signal for all shareholders
- Registration rights amendment could lead to future dilution if Cynosure exercises demand registration for a secondary sale
- Insider buying cluster may be partially offset by the company's high SG&A growth (16.7% of revenue vs 15.4% prior year)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-BRCB-1779500557897 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | Press Release | $9.81 | awaiting T+60 | — | $9.99 (+1.83%) |
Oct 9, 2026 17d ago | SC 13G | $7.25 | awaiting T+60 | — | $9.99 (+37.79%) |
Sep 25, 2026 4w ago | Press Release | $7.19 | awaiting T+60 | — | $9.99 (+38.94%) |
Sep 25, 2026 4w ago | Press Release | $7.19 | awaiting T+60 | — | $9.99 (+38.94%) |
Sep 11, 2026 6w ago | Press Release | $8.48 | awaiting T+60 | — | $9.99 (+17.81%) |
Sep 1, 2026 7w ago | Press Release | $9.54 | awaiting T+60 | — | $9.99 (+4.72%) |
Aug 28, 2026 8w ago | Press Release | $9.13 | awaiting T+60 | — | $9.99 (+9.42%) |
Aug 28, 2026 8w ago | Press Release | $9.13 | awaiting T+60 | — | $9.99 (+9.42%) |
Aug 11, 2026 10w ago | Press Release | $8.23 | awaiting T+60 | — | $9.99 (+21.39%) |
Jul 30, 2026 12w ago | Press Release | $7.97 $9.81 | ▲ +23.09% | ▲ +20.62% | $9.99 (+25.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers